U.S. market Closed. Opens in 16 hours 55 minutes

SWTX | SpringWorks Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue5.45M6.15MN/A35.00MN/AN/A
Cost of Revenue422.00K1.90M490.00K349.00K192.00KN/A
Gross Profit5.03M4.25M-490.00K34.65M-192.00KN/A
Operating Expenses348.04M280.67M173.47M81.32M59.24M18.49M
Selling, General & Admin197.55M134.55M71.79M29.46M16.69M8.59M
Research & Development150.49M146.12M101.68M51.86M42.55M9.90M
Other Operating ExpensesN/A-138.00K-152.00K25.00KN/AN/A
Operating Income-343.01M-280.67M-173.47M-46.32M-59.24M-18.49M
Other Expenses / Income-5.04M3.26M-442.00K750.00K933.00K678.00K
Before Tax Income-325.10M-277.42M-173.91M-45.57M-58.31M-17.81M
Income Tax Expenses-22.95M-3.26M-698.00K-1.33M-3.55M678.00K
Net Income-325.10M-274.16M-173.21M-44.24M-54.76M-17.81M
Interest ExpensesN/A-765.00KN/AN/AN/AN/A
Basic Shares Outstanding63.12M53.29M48.50M43.30M43.01M22.20M
Diluted Shares Outstanding63.12M53.29M48.50M43.30M43.01M22.20M
EBITDA-341.35M-280.67M-172.98M-45.98M-59.05M-18.47M
EBITDA Margin-6,266.68%-4,566.03%0.00%-131.36%0.00%0.00%
EBIT-348.05M-278.18M-173.91M-45.57M-58.31M-17.14M
EBIT Margin-6,389.77%-4,525.49%0.00%-130.21%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙